Department of Health Science, Aichi Gakuin University, 12 Araike, Iwasaki-cho, Nisshin-city, Aichi, Japan; Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan.
Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan.
Parkinsonism Relat Disord. 2021 Dec;93:8-11. doi: 10.1016/j.parkreldis.2021.10.029. Epub 2021 Nov 4.
The impact of deep brain stimulation (DBS) on speech rhythm and its mechanism remains unclear. We investigated speech rhythm characteristics of patients with Parkinson's disease (PD) treated with subthalamic nucleus (STN) DBS to understand the underlying pathophysiology better.
We enrolled a total of 105 participants and evaluated speech rhythm performances among patients with PD who had undergone STN-DBS (the PD-DBS group), patients with PD treated only with medication (the PD-Med group), patients with cerebellar ataxia (the CA group), and healthy controls (the HC group). Each participant was asked to repeat the syllable/pa/at a comfortable self-chosen steady pace. A widely-used software (the Motor Speech Profile) program performed an acoustic analysis.
Compared to the PD-Med and HC groups, speech rate instability (DDKjit) was significantly higher in the PD-DBS and CA groups (p < 0.01). However, after DBS was turned off, the DDKjit of the PD-DBS group improved to a level comparable to that of the PD-Med and HC groups. In contrast to the significantly higher variability of speech volume (DDKcvi) in the CA group, the PD-DBS group showed similar DDKcvi to the PD-Med and HC groups.
STN-DBS affects the speech rate stability of patients with PD. Speech rhythm disorders caused by STN-DBS were phenotypically similar to that in CA in terms of interval variability but different regarding amplitude variability. Further studies are warranted to elucidate the underlying pathophysiology of speech rhythm disorders in PD patients treated with DBS.
深部脑刺激(DBS)对言语节律的影响及其机制尚不清楚。我们研究了接受丘脑底核(STN)DBS 治疗的帕金森病(PD)患者的言语节律特征,以更好地了解潜在的病理生理学。
我们共纳入 105 名参与者,评估了接受 STN-DBS 治疗的 PD 患者(PD-DBS 组)、仅接受药物治疗的 PD 患者(PD-Med 组)、小脑共济失调患者(CA 组)和健康对照组(HC 组)的言语节律表现。每位参与者被要求以舒适的自定稳定速度重复音节/pa/。一个广泛使用的软件(Motor Speech Profile 程序)进行了声学分析。
与 PD-Med 组和 HC 组相比,PD-DBS 组和 CA 组的言语率不稳定性(DDKjit)明显更高(p<0.01)。然而,关闭 DBS 后,PD-DBS 组的 DDKjit 改善到与 PD-Med 组和 HC 组相当的水平。与 CA 组言语音量变异性(DDKcvi)显著增加相比,PD-DBS 组的 DDKcvi 与 PD-Med 组和 HC 组相似。
STN-DBS 影响 PD 患者的言语率稳定性。STN-DBS 引起的言语节律障碍在间隔变异性方面与 CA 相似,但在幅度变异性方面不同。需要进一步研究阐明接受 DBS 治疗的 PD 患者言语节律障碍的潜在病理生理学。